You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

  Results, filtered by:  

Filter by

148 {0} - {1} of {2} items

GSK UK Products

This site provides information on GSK medicines and vaccines for members of the UK public, patients and their carers.

Mivacron

Mivacron (mivacurium chloride) links to the summary of product characteristics and patient information leaflet to support UK patients and carers when prescribed.

Ambirix product overview

Ambirix product information to support UK patients and carers when prescribed.

Contact us

GSK UK contact us page for members of the UK public

Products | GSK public UK

GSK product information for UK members of the public and patients

Report suspected side effect

Form for UK members of the public and patients that have been prescribed a GSK medicine or vaccine to report a suspected side effect

Haleraid | GSK public

Haleraid is a device developed to help patients with impaired hand agility administer a range of GSK inhalers.

Zejula (niraparib) | I am a patient

Zejula (niraparib) patient support materials to help guide advanced ovarian cancer patients.

▼ JEMPERLI (dostarlimab) | GSK public UK

▼JEMPERLI (dostarlimab) information for UK members of the public.

Zejula (niraparib)

Information for members of public on Zejula (niraparib)

Ellipta – About the Ellipta device | GSK Pharma UK | Public site

A product overview of the Ellipta device for members of the public or for patients prescribed an Ellipta medicine in the UK.

Engerix B

Information on Engerix B vaccine for members of public including summary of product characteristics and patient information leaflet

Ambirix

Information on Ambirix vaccine for members of public including summary of product characteristics and patient information leaflet

Havrix Junior Monodose

Information on Havrix Junior Monodose vaccine for members of public including summary of product characteristics and patient information leaflet

Havrix Monodose

Information on Havrix Monodose vaccine for members of public including summary of product characteristics and patient information leaflet

Twinrix

Information on Twinrix vaccine for members of public including summary of product characteristics and patient information leaflet

Engerix B Paediatrics

Information on Engerix B Paediatrics vaccine for members of public including summary of product characteristics and patient information leaflet

Twinrix Paediatrics

Information on Twinrix Paediatrics vaccine for members of public including summary of product characteristics and patient information leaflet

Menveo

Information on Menveo vaccine for members of public including summary of product characteristics and patient information leaflet

Fendrix

Information on Fendrix vaccine for members of public including summary of product characteristics and patient information leaflet

Infanrix-IPV+Hib (Diptheria, tetanus, pertussis (acellular), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine adsorbed)) | GSK Public UK

Information on Infanrix-IPV+Hib (Diptheria, tetanus, pertussis (acellular), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine adsorbed)) for members of public including summary of product characteristics and patient information leaflet

Varilrix (live attenuated varicella-zoster (Oka strain) virus) | GSK Public UK

Information on Varilrix (live attenuated varicella-zoster (Oka strain) virus) for members of public including summary of product characteristics and patient information leaflet

Menitorix (hib, meningococcal group c combined vaccine) | GSK Public UK

Information on Menitorix (hib, meningococcal group c combined vaccine) for members of public including summary of product characteristics and patient information leaflet

AREXVY ▼

AREXVY patient information for members of the UK public

Bexsero

Information on Bexsero vaccine for members of public including summary of product characteristics and patient information leaflet.

MOP | SHINGRIX landing page

SHINGRIX patient information for members of the UK public

Omjjara ▼ (momelotinib) | GSK public UK

Omjjara ▼ (momelotinib) | Information for members of the public

Ventolin (salbutamol) | GSK public UK

Ventolin (salbutamol) support for members of the public.

Bexsero overview

Information on Bexsero vaccine for members of public including summary of product characteristics and patient information leaflet.

Boostrix-IPV (diphtheria, tetanus, pertussis (acellular) and poliomyelitis (inactivated)) | GSK Public UK

Information on Boostrix-IPV (diphtheria, tetanus, pertussis (acellular) and poliomyelitis (inactivated)) for members of public including summary of product characteristics and patient information leaflet

Relenza (zanamivir) | GSK Public UK

Information on Relenza (zanamivir) for members of public including summary of product characteristics and patient information leaflet

Priorix (Measles, Mumps and Rubella vaccine (live)) | GSK Public UK

Information on Priorix (Measles, Mumps and Rubella vaccine (live)) for members of public including summary of product characteristics and patient information leaflet

Rotarix (live attenuated rotavirus vaccine) | GSK Public UK

Information on Rotarix (live attenuated rotavirus vaccine) for members of public including summary of product characteristics and patient information leaflet

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) – Possible side effects

Information for patients who have been prescribed Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) in the UK. Information about the possible side effects.

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) – FAQs

Information for patients who have been prescribed Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) in the UK. Frequently asked questions.

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) – I am a patient

Information for patients who have been prescribed Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) in the UK. Including how to use the device and side effects.

TrelegyEllipta (fluticasone furoate/umeclidinium/vilanterol) – COPD Information

Information for patients who have been prescribed TrelegyEllipta (fluticasone furoate/umeclidinium/vilanterol) in the UK. Links to professional organisations, charities and other useful websites for COPD.

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) – My Medicine

Information for patients who have been prescribed Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) in the UK.

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) product information for the UK members of the public

I am a patient

Information about how to use the Ellipta device for UK patients who have been prescribed a medicine to be taken via Ellipta.

Show more

- This medicine is subject to additional monitoring. This will allow quick identification of new safety information.

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the Patient information leaflet.

You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store.

By reporting side effects you can help provide more information on the safety of this medicine.